Sign Up Today and Learn More About Locanabio Stock
Invest in or calculate the value of your shares in Locanabio or other pre-IPO companies through EquityZen's platform.
Locanabio Stock (LOCA)
Locana develops RNA-targeting gene therapies for patients with severe neurodegenerative, neuromuscular, and retinal diseases.
About Locanabio Stock
Founded
2016
Headquarters
San Diego, CA, US
Industries
Science and Engineering, Health Care, Biotechnology
Locanabio, Inc., is an RNA-targeting gene therapy company focused on developing therapies for patients with severe neurodegenerative, neuromuscular, and retinal diseases.
Locanabio Press Mentions
Stay in the know about the latest news on Locanabio
Rna-targeting compositions and methods for treating cag repeat diseases
patents • Apr 02, 2025
Compositions and methods comprising programmable snrnas for rna editing
patents • Feb 09, 2025
Compositions and methods for modulating pre-mrna splicing
patents • Feb 09, 2025
Rna-targeting compositions and methods for treating myotonic dystrophy type 1
patents • Feb 09, 2025
Compositions and methods comprising engineered short nuclear rna (snrna)
patents • Apr 14, 2024
Locanabio Management
Leadership team at Locanabio
Scientific Advisory Board Member
Edward Conner
Chairman
Thomas Daniel
Join now and verify your accreditation status to gain access to:
- Locanabio Current Valuation
- Locanabio Stock Price
- Locanabio Management
- Available deals in Locanabio and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Locanabio Cap Table and Funding History by Share Class and Liquidity Preferences
- Locanabio Revenue and Financials
- Locanabio Highlights
- Locanabio Business Model
- Locanabio Risk Factors
- Locanabio Research Report from SACRA Research
Trading Locanabio Stock
How to invest in Locanabio stock?
Accredited investors can buy pre-IPO stock in companies like Locanabio through EquityZen funds. These investments are made available by existing Locanabio shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Locanabio stock?
Shareholders can sell their Locanabio stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
